Research map: Prognostic performance of liver stiffness measurements in primary sclerosing cholangitis: the prospective FICUS cohort

Back to the article

Papers in this map

  1. Baveno VII – Renewing consensus in portal hypertension · Roberto de Franchis · 2021 · 2898 citations · Cited by this paper
  2. The Many Challenges of Necrotizing Pancreatitis · 2026 · Related
  3. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis · Laurent Sandrin · 2003 · 2749 citations · Cited by this paper
  4. Elsewhere in the AGA Journals (Preview Section) · 2026 · Related
  5. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update · Annalisa Berzigotti · 2021 · 1896 citations · Cited by this paper
  6. CME Exam 1: Biofeedback Guided by Thoracoabdominal Wall Motion for the Treatment of Rumination: A Randomized Placebo-Controlled Trial · 2026 · Related
  7. Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations · Laurent Castéra · 2009 · 1164 citations · Cited by this paper
  8. Acute Liver Failure in a Patient With Myasthenia Gravis · 2026 · Related
  9. Primary sclerosing cholangitis – a comprehensive review · Tom H. Karlsen · 2017 · 880 citations · Cited by this paper
  10. Methodological Considerations on Central Pathology Review in Artificial Intelligence-Assisted Gastric Neoplasm Detection · 2026 · Related
  11. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis · Annika M Bergquist · 2002 · 718 citations · Cited by this paper
  12. An Unusual Cause of Chronic Hematochezia · 2026 · Related
  13. Determination of reliability criteria for liver stiffness evaluation by transient elastography · Jérôme Boursier · 2012 · 660 citations · Cited by this paper
  14. BIRC3 (Encoding cIAP2) Variants Result in Dysregulated RIPK1 Signaling Leading to Increased Epithelial Cell Death and Are Associated With Monogenic Crohn’s Disease · 2026 · Related
  15. Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy · Christophe Cassinotto · 2015 · 523 citations · Cited by this paper
  16. Gastro Grand Rounds:Managing Complex IBS: A Multidisciplinary, Mechanism-Based Approach · 2026 · Related
  17. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma · Christopher L. Bowlus · 2022 · 423 citations · Cited by this paper
  18. Reply · 2026 · Related
  19. EASL Clinical Practice Guidelines on sclerosing cholangitis · Olivier Chazouillères · 2022 · 411 citations · Cited by this paper
  20. A Revised Natural History Model for Primary Sclerosing Cholangitis · W. RAY KIM · 2000 · 349 citations · Cited by this paper
  21. Baseline Values and Changes in Liver Stiffness Measured by Transient Elastography Are Associated With Severity of Fibrosis and Outcomes of Patients With Primary Sclerosing Cholangitis · Christophe Corpechot · 2014 · 298 citations · Cited by this paper
  22. Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease · Huapeng Lin · 2024 · 242 citations · Cited by this paper
  23. New therapeutic concepts in bile acid transport and signaling for management of cholestasis · Michael A Trauner · 2016 · 228 citations · Cited by this paper
  24. TheRPackageJMbayesfor Fitting Joint Models for Longitudinal and Time-to-Event Data Using MCMC · Dimitris Rizopoulos · 2016 · 219 citations · Cited by this paper
  25. Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution · Umberto Arena · 2013 · 193 citations · Cited by this paper
  26. Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process · Cyriel Y. Ponsioen · 2015 · 180 citations · Cited by this paper
  27. A novel prognostic model for transplant-free survival in primary sclerosing cholangitis · Elisabeth M. de Vries · 2017 · 138 citations · Cited by this paper
  28. Enhanced liver fibrosis score predicts transplant‐free survival in primary sclerosing cholangitis · Mette Nåmdal Vesterhus · 2015 · 137 citations · Cited by this paper
  29. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis · Christophe Corpechot · 2022 · 123 citations · Cited by this paper
  30. Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease · Georg Semmler · 2023 · 108 citations · Cited by this paper
  31. Noninvasive Assessment of Liver Fibrosis · Laurent Castéra · 2025 · 99 citations · Cited by this paper
  32. Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD · Samer Gawrieh · 2024 · 87 citations · Cited by this paper
  33. Significant Variations in Elastometry Measurements Made Within Short-term in Patients With Chronic Liver Diseases · Fabio Nascimbeni · 2014 · 83 citations · Cited by this paper
  34. Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis · Cyriel Y. Ponsioen · 2018 · 74 citations · Cited by this paper
  35. Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis · Hanno Ehlken · 2016 · 69 citations · Cited by this paper
  36. Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease · Katrine Holtz Thorhauge · 2024 · 47 citations · Cited by this paper
  37. Reproducibility and Repeatability of US Shear-Wave and Transient Elastography in Nonalcoholic Fatty Liver Disease · Theodore T. Pierce · 2024 · 46 citations · Cited by this paper
  38. Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis · Laurent Lam · 2024 · 39 citations · Cited by this paper
  39. Non-invasive tests: Establishing efficacy for metabolic dysfunction–associated steatohepatitis beyond the biopsy—Current perspectives from the Division of Hepatology and Nutrition, US Food and Drug Administration · Frank A. Anania · 2025 · 25 citations · Cited by this paper

Source: OpenAlex (CC0)